Trials / Completed
CompletedNCT06989710
Radicle Health 24: A Study of Health and Wellness Products on Overall Health
Radicle HealthTM 24: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Overall Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,700 (actual)
- Sponsor
- Radicle Science · Industry
- Sex
- All
- Age
- 21 Years – 105 Years
- Healthy volunteers
- Accepted
Summary
A randomized, double-blind, placebo-controlled direct-to-consumer study of health and wellness products on overall health
Detailed description
This is a randomized, double-blind, placebo-controlled study conducted with adult participants, residing in the United States. Eligible participants will (1) endorse a desire for better overall health, (2) have the opportunity for meaningful improvement (at least 30%) in their primary health outcome, and (3) express acceptance in taking a product and not knowing its formulation until the end of the study. Participants that report a known cardiac dysfunction, liver or kidney disease may be excluded. Participants that report a known contraindication or with well-established, significant safety concerns due to illness will be excluded. Heavy drinkers and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Participants that report taking medications with a known contraindication or with well-established, significant safety concerns will be excluded. Self-reported data are collected electronically from eligible participants for 7 weeks. Participant reports of health indicators will be collected at baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo control 7.1.0 | Participants will use their placebo control 7.1.0 as directed for a period of 6 weeks. |
| DIETARY_SUPPLEMENT | Health Active Product 7.1.1 usage | Participants will use their Radicle Health Active Study Product 7.1.1 as directed for a period of 6 weeks. |
| DIETARY_SUPPLEMENT | Health Active Product 7.1.2 usage | Participants will use their Radicle Health Active Study Product 7.1.2 as directed for a period of 6 weeks. |
| DIETARY_SUPPLEMENT | Placebo control 7.2.0 | Participants will use their placebo control 7.2.0 as directed for a period of 6 weeks. |
| DIETARY_SUPPLEMENT | Health Active Product 7.2.1 usage | Participants will use their Radicle Health Active Study Product 7.2.1 as directed for a period of 6 weeks. |
Timeline
- Start date
- 2025-05-02
- Primary completion
- 2025-09-19
- Completion
- 2025-09-19
- First posted
- 2025-05-25
- Last updated
- 2025-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06989710. Inclusion in this directory is not an endorsement.